Gregory J Divis insider trades
Open-market stock purchases and sales by Gregory J Divis, Chief Executive Officer at Avadel Pharmaceuticals plc, from SEC Form 4 filings since Mar 20, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $210K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $4.4M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $1.6M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $353K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $185K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $684K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $3.4M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $1.6M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $8.1M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $2.4M |